🇺🇸 FDA

Intelligence Platform

Patents

Browse 373 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 7422867

Methods of identifying compounds that modulate IL-4 receptor mediated IgE synthesis utiliz

Rigel Pharmaceuticals, Inc. · Granted Tue Sep 09 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 04 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7420045

IAPs associated cell cycle proteins, compositions and methods of use

Rigel Pharmaceuticals, Inc. · Granted Tue Sep 02 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 28 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7413870

SAK: modulation of cellular proliferation for treatment of cancer

Rigel Pharmaceuticals, Inc. · Granted Tue Aug 19 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 14 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7410979

Synergistically effective combinations of dihaloacetamide compounds and interferon or riba

Rigel Pharmaceuticals, Inc. · Granted Tue Aug 12 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 07 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7378251

Methods of identifying compounds that modulate IL-4 receptor-mediated IgE synthesis utiliz

Rigel Pharmaceuticals, Inc. · Granted Tue May 27 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 22 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7368257

Modulators of lymphocyte activation, Mkk3b compositions and methods of use

Rigel Pharmaceuticals, Inc. · Granted Tue May 06 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 01 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7358259

HCV inhibitors and methods of using them

Rigel Pharmaceuticals, Inc. · Granted Tue Apr 15 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 10 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7332602

Pyridyl substituted heterocycles useful for treating or preventing HCV infection

Rigel Pharmaceuticals, Inc. · Granted Tue Feb 19 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 14 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7332484

2,4-pyrimidinediamine compounds and their uses

Rigel Pharmaceuticals, Inc. · Granted Tue Feb 19 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 14 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7329672

2,4-pyrimidinediamine compounds and their uses

Rigel Pharmaceuticals, Inc. · Granted Tue Feb 12 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 07 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7329671

2,4-pyrimidinediamine compounds and their uses

Rigel Pharmaceuticals, Inc. · Granted Tue Feb 12 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 07 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7326790

Diphenylisoxazole compounds and hydro isomers thereof

Rigel Pharmaceuticals, Inc. · Granted Tue Feb 05 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 31 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7285383

Method for selective inactivation of viral replication

Rigel Pharmaceuticals, Inc. · Granted Tue Oct 23 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 18 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7244576

Modulators of angiogenesis

Rigel Pharmaceuticals, Inc. · Granted Tue Jul 17 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 12 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7241581

Methods of identifying compounds that modulate IL-4 receptor-mediated IgE synthesis utiliz

Rigel Pharmaceuticals, Inc. · Granted Tue Jul 10 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 05 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7220745

Heterocyclic compounds useful to treat HCV

Rigel Pharmaceuticals, Inc. · Granted Tue May 22 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 17 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7208289

Methods of identifying compounds that modulate IL-4 receptor mediated IgE synthesis utiliz

Rigel Pharmaceuticals, Inc. · Granted Tue Apr 24 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 19 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7157473

Pyridyl substituted heterocycles useful for treating or preventing HCV infection

Rigel Pharmaceuticals, Inc. · Granted Tue Jan 02 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 28 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7153880

Substituted diphenyl heterocycles useful for treating HCV infection

Rigel Pharmaceuticals, Inc. · Granted Tue Dec 26 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 21 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7141434

Methods of identifying compounds that modulate IL-4 receptor-mediated IgE synthesis utiliz

Rigel Pharmaceuticals, Inc. · Granted Tue Nov 28 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 23 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7122542

Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds

Rigel Pharmaceuticals, Inc. · Granted Tue Oct 17 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 12 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7060827

Intermediates useful for making 2,4-pyrimidinediamine compounds

Rigel Pharmaceuticals, Inc. · Granted Tue Jun 13 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 08 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7045284

Method for selective inactivation of viral replication

Rigel Pharmaceuticals, Inc. · Granted Tue May 16 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 11 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6979549

Methods of identifying compounds that modulate IL-4 receptor-mediated IgE synthesis utiliz

Rigel Pharmaceuticals, Inc. · Granted Tue Dec 27 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 22 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

expired